ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001557832

Gallagher Cam

CIK 0001557832 Name as filed on the most recent filing

Filed as Gallagher Cam (43)

138 transaction lines · from 43 filings · filed 2020-11-25 to 2025-12-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

138 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2022-01-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,641 disposed 76.03 276,808.85 Form 4, filing 0001725160-22-000004
2022-01-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,397 disposed 73.18 175,407.43 Form 4, filing 0001725160-22-000004
2022-01-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,156 disposed 78.24 90,450.53 Form 4, filing 0001725160-22-000004
2022-01-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,106 disposed 76.90 85,054.28 Form 4, filing 0001725160-22-000004
2022-01-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 900 disposed 73.92 66,524.04 Form 4, filing 0001725160-22-000004
2022-01-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 700 disposed 75.32 52,724.98 Form 4, filing 0001725160-22-000004
2022-01-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 100 disposed 78.91 7,891.00 Form 4, filing 0001725160-22-000004
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,001 disposed 71.28 213,914.58 Form 4, filing 0001725160-21-000240
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,900 disposed 73.35 139,362.91 Form 4, filing 0001725160-21-000240
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,524 disposed 78.21 119,197.98 Form 4, filing 0001725160-21-000240
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,117 disposed 74.50 83,213.37 Form 4, filing 0001725160-21-000240
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,100 disposed 72.01 79,210.01 Form 4, filing 0001725160-21-000240
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 527 disposed 78.97 41,614.61 Form 4, filing 0001725160-21-000240
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 520 disposed 77.24 40,166.78 Form 4, filing 0001725160-21-000240
2021-12-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 311 disposed 76.07 23,656.40 Form 4, filing 0001725160-21-000240
2021-12-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 10,000 disposed 71.33 713,300.00 Form 4, filing 0001725160-21-000235
2021-11-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 6,614 disposed 75.02 496,192.20 Form 4, filing 0001725160-21-000224
2021-11-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,400 disposed 75.76 181,832.88 Form 4, filing 0001725160-21-000224
2021-11-15 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 986 disposed 76.67 75,593.96 Form 4, filing 0001725160-21-000224
2021-11-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 5,094 disposed 82.98 422,678.73 Form 4, filing 0001725160-21-000213
2021-11-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,506 disposed 82.09 205,725.81 Form 4, filing 0001725160-21-000213
2021-11-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,400 disposed 83.79 201,086.40 Form 4, filing 0001725160-21-000213
2021-10-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 4,820 disposed 66.77 321,829.95 Form 4, filing 0001725160-21-000201
2021-10-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,664 disposed 65.77 175,217.14 Form 4, filing 0001725160-21-000201
2021-10-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,900 disposed 64.71 122,941.02 Form 4, filing 0001725160-21-000201
2021-10-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 616 disposed 67.37 41,501.40 Form 4, filing 0001725160-21-000201
2021-09-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 6,241 disposed 67.23 419,571.82 Form 4, filing 0001725160-21-000191
2021-09-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,759 disposed 68.01 255,657.48 Form 4, filing 0001725160-21-000191
2021-08-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 4,812 disposed 51.35 247,106.31 Form 4, filing 0001725160-21-000174
2021-08-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,784 disposed 49.94 188,990.37 Form 4, filing 0001725160-21-000174
2021-08-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,100 disposed 52.59 57,846.69 Form 4, filing 0001725160-21-000174
2021-08-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 304 disposed 53.47 16,254.48 Form 4, filing 0001725160-21-000174
2021-07-07 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,050 disposed 47.28 49,644.10 Form 4, filing 0001725160-21-000169
2021-07-07 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 858 disposed 47.76 40,980.31 Form 4, filing 0001725160-21-000169
2021-07-07 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 664 disposed 46.08 30,596.06 Form 4, filing 0001725160-21-000169
2021-07-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 11,764 disposed 46.85 551,132.81 Form 4, filing 0001725160-21-000169
2021-07-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,796 disposed 46.78 130,804.15 Form 4, filing 0001725160-21-000169
2021-07-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 769 disposed 47.17 36,271.27 Form 4, filing 0001725160-21-000169
2021-07-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 315 disposed 47.28 14,894.37 Form 4, filing 0001725160-21-000169
2021-07-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 100 disposed 48.96 4,896.00 Form 4, filing 0001725160-21-000169
2021-07-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 54 disposed 48.83 2,637.04 Form 4, filing 0001725160-21-000169
2021-07-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 5,977 disposed 49.80 297,646.23 Form 4, filing 0001725160-21-000161
2021-07-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,823 disposed 49.18 188,008.26 Form 4, filing 0001725160-21-000161
2021-07-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 200 disposed 50.86 10,172.04 Form 4, filing 0001725160-21-000161
2021-06-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 8,728 disposed 53.97 471,089.44 Form 4, filing 0001725160-21-000137
2021-06-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,272 disposed 54.61 69,461.88 Form 4, filing 0001725160-21-000137
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 5,804 disposed 60.07 348,643.96 Form 4, filing 0001725160-21-000119
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,992 disposed 58.08 115,696.16 Form 4, filing 0001725160-21-000119
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,200 disposed 57.08 68,499.72 Form 4, filing 0001725160-21-000119
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,004 disposed 59.43 59,664.41 Form 4, filing 0001725160-21-000119

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 135
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Gallagher Cam, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001557832

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.